|
1
|
Asakura K, Nishiwaki Y, Inoue N, Hibi T,
Watanabe M and Takebayashi T: Prevalence of ulcerative colitis and
Crohn's disease in Japan. J Gastroenterol. 44:659–665. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Podolsky DK: Inflammatory bowel disease
(1). N Engl J Med. 325:928–937. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goldsmith JR and Sartor RB: The role of
diet on intestinal microbiota metabolism: Downstream impacts on
host immune function and health, and therapeutic implications. J
Gastroenterol. 49:785–798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simrén M and Stotzer PO: Use and abuse of
hydrogen breath tests. Gut. 55:297–303. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gearry RB, Irving PM, Barrett JS, Nathan
DM, Shepherd SJ and Gibson PR: Reduction of dietary poorly absorbed
short-chain carbohydrates (FODMAPs) improves abdominal symptoms in
patients with inflammatory bowel disease-a pilot study. J Crohn's
Colitis. 3:8–14. 2009. View Article : Google Scholar
|
|
6
|
Li YC and Hsieh CC: Lactoferrin dampens
high-fructose corn syrup-induced hepatic manifestations of the
metabolic syndrome in a murine model. PLoS One. 9:e973412014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Assy N, Nasser G, Kamayse I, Nseir W,
Beniashvili Z, Djibre A and Grosovski M: Soft drink consumption
linked with fatty liver in the absence of traditional risk factors.
Can J Gastroenterol. 22:811–816. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Walker RW, Dumke KA and Goran MI: Fructose
content in popular beverages made with and without high-fructose
corn syrup. Nutrition. 30:928–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones HF, Butler RN and Brooks DA:
Intestinal fructose transport and malabsorption in humans. Am J
Physiol Gastrointest Liver Physiol. 300:G202–G206. 2011. View Article : Google Scholar
|
|
10
|
Arkan MC, Hevener AL, Greten FR, Maeda S,
Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J and Karin M:
IKK-beta links inflammation to obesity-induced insulin resistance.
Nat Med. 11:191–198. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diehl AM, Li ZP, Lin HZ and Yang SQ:
Cytokines and the pathogenesis of non-alcoholic steatohepatitis.
Gut. 54:303–306. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi H, Kokoeva MV, Inouye K, Tzameli I,
Yin H and Flier JS: TLR4 links innate immunity and fatty
acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gäbele E, Dostert K, Hofmann C, Wiest R,
Schölmerich J, Hellerbrand C and Obermeier F: DSS induced colitis
increases portal LPS levels and enhances hepatic inflammation and
fibro-genesis in experimental NASH. J Hepatol. 55:1391–1399. 2011.
View Article : Google Scholar
|
|
14
|
Lírio LM, Forechi L, Zanardo TC, Batista
HM, Meira EF, Nogueira BV, Mill JG and Baldo MP: Chronic fructose
intake accelerates non-alcoholic fatty liver disease in the
presence of essential hypertension. J Diabetes Complications.
30:85–92. 2016. View Article : Google Scholar
|
|
15
|
Mohammed A, Koorbanally NA and Islam MS:
Ethyl acetate fraction of Aframomum melegueta fruit ameliorates
pancreatic β-cell dysfunction and major diabetes-related parameters
in a type 2 diabetes model of rats. J Ethnopharmacol. 175:518–527.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Malik VS and Hu FB: Fructose and
cardiometabolic health: What the evidence from sugar-sweetened
beverages tells us. J Am Coll Cardiol. 66:1615–1624. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanoue S, Uto H, Kumamoto R, Arima S,
Hashimoto S, Nasu Y, Takami Y, Moriuchi A, Sakiyama T, Oketani M,
et al: Liver regeneration after partial hepatectomy in rat is more
impaired in a steatotic liver induced by dietary fructose compared
to dietary fat. Biochem Biophys Res Commun. 407:163–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wigg AJ, Roberts-Thomson IC, Dymock RB,
McCarthy PJ, Grose RH and Cummins AG: The role of small intestinal
bacterial overgrowth, intestinal permeability, endotoxaemia, and
tumour necrosis factor alpha in the pathogenesis of non-alcoholic
steatohepatitis. Gut. 48:206–211. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brun P, Castagliuolo I, Floreani AR, Buda
A, Blasone L, Palù G and Martines D: Increased risk of NASH in
patients carrying the C(-159)T polymorphism in the CD14 gene
promoter region. Gut. 55:12122006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin Y, Lin Y, Lin L, Sun Y and Zheng C:
Carcinoembryonic antigen related cellular adhesion molecule 1
alleviates dextran sulfate sodium-induced ulcerative colitis in
mice. Life Sci. 149:120–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barnett MP, Dommels YE, Butts CA, Zhu S,
McNabb WC and Roy NC: Inoculation with enterococci does not affect
colon inflammation in the multi-drug resistance 1a-deficient mouse
model of IBD. BMC Gastroenterol. 16:312016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Raup-Konsavage WM, Cooper TK and Yochum
GS: A role for MYC in lithium-stimulated repair of the colonic
epithelium after DSS-induced damage in mice. Dig Dis Sci.
61:410–422. 2016. View Article : Google Scholar
|
|
23
|
Park JS, Yi TG, Park JM, Han YM, Kim JH,
Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS, et al: Therapeutic effects
of mouse bone marrow-derived clonal mesenchymal stem cells in a
mouse model of inflammatory bowel disease. J Clin Biochem Nutr.
57:192–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eirheim HU, Bundgaard C and Nielsen HM:
Evaluation of different toxicity assays applied to proliferating
cells and to stratified epithelium in relation to permeability
enhancement with glycocholate. Toxicol In Vitro. 18:649–657. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spruss A, Kanuri G, Stahl C, Bischoff SC
and Bergheim I: Metformin protects against the development of
fructose-induced steatosis in mice: Role of the intestinal barrier
function. Lab Invest. 92:1020–1032. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haub S, Kanuri G, Volynets V, Brune T,
Bischoff SC and Bergheim I: Serotonin reuptake transporter (SERT)
plays a critical role in the onset of fructose-induced hepatic
steatosis in mice. Am J Physiol Gastrointest Liver Physiol.
298:G335–G344. 2010. View Article : Google Scholar
|
|
27
|
Sellmann C, Priebs J, Landmann M, Degen C,
Engstler AJ, Jin CJ, Gärttner S, Spruss A, Huber O and Bergheim I:
Diets rich in fructose, fat or fructose and fat alter intestinal
barrier function and lead to the development of nonalcoholic fatty
liver disease over time. J Nutr Biochem. 26:1183–1192. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jourdan T, Godlewski G, Cinar R, Bertola
A, Szanda G, Liu J, Tam J, Han T, Mukhopadhyay B, Skarulis MC, et
al: Activation of the Nlrp3 inflammasome in infiltrating
macrophages by endocannabinoids mediates beta cell loss in type 2
diabetes. Nat Med. 19:1132–1140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bergheim I, Weber S, Vos M, Krämer S,
Volynets V, Kaserouni S, McClain CJ and Bischoff SC: Antibiotics
protect against fructose-induced hepatic lipid accumulation in
mice: Role of endotoxin. J Hepatol. 48:983–992. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi VM, Herrou J, Hecht AL, Teoh WP,
Turner JR, Crosson S and Bubeck Wardenburg J: Activation of
Bacteroides fragilis toxin by a novel bacterial protease
contributes to anaerobic sepsis in mice. Nat Med. 22:563–567. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wexler HM: Bacteroides: The good, the bad,
and the nitty-gritty. Clin Microbiol Rev. 20:593–621. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Do MH, Lee E, Oh MJ, Kim Y and Park HY:
High-glucose or -fructose diet cause changes of the gut microbiota
and metabolic disorders in mice without body weight change.
Nutrients. 10:E7612018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mastrocola R, Ferrocino I, Liberto E,
Chiazza F, Cento AS, Collotta D, Querio G, Nigro D, Bitonto V,
Cutrin JC, et al: Fructose liquid and solid formulations
differently affect gut integrity, microbiota composition and
related liver toxicity: A comparative in vivo study. J Nutr
Biochem. 55:185–199. 2018. View Article : Google Scholar : PubMed/NCBI
|
